Neo Ivy Capital Management’s Halozyme HALO Stock Holding History

Neo Ivy Capital Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$400K	Buy	+5,106	New	+$348K	0.09%	238
2025 Q4	–	Sell	-5,386	Closed	-$395K	–	428
2025 Q3	$395K	Sell	5,386 -18,687	-78%	-$1.24M	0.1%	260
2025 Q2	$1.25M	Buy	+24,073	New	+$1.37M	0.4%	89
2023 Q4	$207K	Buy	+5,602	New	+$211K	0.46%	58
2021 Q4	–	Sell	-18,496	Closed	-$496K	–	508
2021 Q3	$496K	Buy	18,496 +17,205	+1,333%	+$719K	0.57%	49
2021 Q2	$59K	Sell	1,291 -1,675	-56%	-$74.1K	0.06%	307
2021 Q1	$124K	Sell	2,966 -4,986	-63%	-$228K	0.14%	215
2020 Q4	$340K	Sell	7,952 -943	-11%	-$33.9K	0.38%	91
2020 Q3	$233K	Sell	8,895 -9,601	-52%	-$267K	0.24%	168
2020 Q2	$496K	Buy	18,496 +16,904	+1,062%	+$381K	0.57%	49
2020 Q1	$29K	Buy	+1,592	New	+$30.2K	0.05%	355
2019 Q4	–	Sell	-23,093	Closed	-$381K	–	315
2019 Q3	$381K	Sell	23,093 -60,873	-72%	-$1M	0.25%	167
2019 Q2	$1.44M	Buy	+83,966	New	+$1.35M	0.81%	17

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Neo Ivy Capital Management's HALO Position: Q2 2026 in Review

Neo Ivy Capital Management opened a new position in Halozyme (HALO) in Q2 2026: 5,106 shares worth $400K. The stake represents 0.09% of the portfolio and ranks #238 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in HALO as recently as Q3 2025.

Neo Ivy Capital Management first reported a position in HALO in Q2 2019 and has held it in 13 quarters since. The position peaked at $1.44M in Q2 2019. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Neo Ivy Capital Management held 5,106 shares of Halozyme worth $400K as of Q2 2026.
Halozyme was a new Neo Ivy Capital Management position in Q2 2026.
Halozyme made up 0.09% of Neo Ivy Capital Management's portfolio in Q2 2026, its #238 holding.
Neo Ivy Capital Management first reported a position in Halozyme in Q2 2019 and has held it in 13 quarters since.
Neo Ivy Capital Management's Halozyme position peaked at $1.44M in Q2 2019.
673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.